First Time Loading...

LifeTech Scientific Corp
HKEX:1302

Watchlist Manager
LifeTech Scientific Corp Logo
LifeTech Scientific Corp
HKEX:1302
Watchlist
Price: 1.68 HKD 2.44% Market Closed
Updated: Apr 27, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

1.3B
+7%
Revenue
Growth Rates:
1 Year
+15%
3 Years
+97%
5 Years
+128%
7 Years
-
10 Years
+448%
360.8m
-6%
Operating Income
Growth Rates:
1 Year
-2%
3 Years
+349%
5 Years
+123%
7 Years
-
10 Years
+699%
263.2m
-20%
Net Income
Growth Rates:
1 Year
-19%
3 Years
+22%
5 Years
+117%
7 Years
-
10 Years
-

Earnings Waterfall
LifeTech Scientific Corp

Revenue
1.3B CNY
Cost of Revenue
-271.5m CNY
Gross Profit
995.6m CNY
Operating Expenses
-634.8m CNY
Operating Income
360.8m CNY
Other Expenses
-97.6m CNY
Net Income
263.2m CNY

Income Statement
LifeTech Scientific Corp

Rotate your device to view
Income Statement
Currency: CNY
Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Revenue
Revenue
126
N/A
133
+6%
140
+5%
153
+9%
161
+5%
172
+7%
181
+5%
190
+4%
201
+6%
209
+4%
231
+11%
176
-24%
409
+133%
480
+17%
557
+16%
618
+11%
669
+8%
633
-5%
642
+1%
830
+29%
925
+11%
1 019
+10%
1 097
+8%
1 182
+8%
1 267
+7%
Gross Profit
Cost of Revenue
(24)
(24)
(27)
(30)
(32)
(36)
(36)
(37)
(37)
(38)
(42)
(35)
(77)
(85)
(102)
(114)
(134)
(135)
(129)
(160)
(178)
(205)
(223)
(244)
(272)
Gross Profit
102
N/A
110
+7%
113
+3%
123
+9%
128
+4%
136
+6%
145
+7%
153
+5%
164
+7%
171
+4%
189
+10%
141
-25%
332
+135%
395
+19%
455
+15%
504
+11%
535
+6%
498
-7%
513
+3%
670
+31%
748
+11%
815
+9%
874
+7%
937
+7%
996
+6%
Operating Income
Operating Expenses
(70)
(83)
(95)
(96)
(96)
(89)
(94)
(98)
(113)
(122)
(143)
(50)
(134)
(201)
(293)
(320)
(346)
(307)
(433)
(497)
(369)
(436)
(507)
(552)
(635)
Selling, General & Administrative
(57)
(66)
(79)
(78)
(77)
(76)
(79)
(84)
(95)
(101)
(115)
(56)
(138)
(165)
(220)
(253)
(287)
(277)
(328)
(358)
(282)
(310)
(349)
(384)
(412)
Research & Development
(17)
(19)
(23)
(26)
(27)
(25)
(24)
(23)
(24)
(27)
(31)
(27)
(62)
(76)
(115)
(132)
(135)
(133)
(162)
(183)
(138)
(181)
(197)
(219)
(286)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(6)
0
(6)
0
(8)
0
(12)
0
(13)
Other Operating Expenses
5
2
7
8
9
11
9
9
6
7
3
34
66
40
42
65
82
103
63
43
59
55
51
51
77
Operating Income
32
N/A
26
-19%
18
-31%
27
+48%
32
+19%
47
+47%
52
+11%
55
+5%
51
-6%
49
-4%
45
-8%
91
+102%
198
+117%
195
-2%
162
-17%
185
+14%
189
+2%
191
+1%
80
-58%
173
+115%
378
+119%
378
+0%
367
-3%
386
+5%
361
-6%
Pre-Tax Income
Interest Income Expense
0
1
(2)
(2)
(2)
(6)
(10)
(89)
(85)
(91)
(98)
1
(4)
3
6
(5)
(18)
(18)
157
184
(51)
(46)
20
12
29
Non-Reccuring Items
(9)
(5)
3
(1)
(1)
(1)
0
0
0
0
(1)
0
0
0
(0)
0
(0)
(0)
5
5
6
9
(9)
(3)
0
Total Other Income
0
0
0
0
0
0
0
(9)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(214)
Pre-Tax Income
23
N/A
22
-5%
19
-14%
24
+27%
30
+21%
40
+36%
42
+4%
(44)
N/A
(34)
+23%
(42)
-23%
(53)
-27%
92
N/A
194
+109%
197
+2%
167
-15%
180
+8%
171
-5%
174
+2%
243
+40%
363
+50%
333
-8%
342
+3%
378
+11%
394
+4%
176
-55%
Net Income
Tax Provision
(8)
(8)
(7)
(7)
(7)
(9)
(9)
(10)
(11)
(11)
(12)
(8)
(30)
(50)
(46)
(34)
(44)
(43)
(36)
(51)
(50)
(48)
(59)
(73)
(68)
Income from Continuing Operations
15
14
13
17
22
31
33
(54)
(45)
(53)
(65)
84
164
147
121
146
127
131
207
312
283
294
319
321
107
Income to Minority Interest
(0)
(0)
(1)
(1)
(0)
(1)
(1)
(0)
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
2
5
9
10
9
9
7
10
156
Net Income (Common)
15
N/A
14
-9%
12
-13%
17
+42%
22
+30%
30
+40%
32
+6%
(54)
N/A
(46)
+16%
(53)
-17%
(66)
-23%
84
N/A
163
+94%
147
-10%
121
-17%
146
+21%
129
-12%
136
+5%
216
+59%
322
+49%
292
-9%
303
+4%
325
+7%
331
+2%
263
-20%
EPS (Diluted)
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
-0.02
N/A
-0.09
-350%
-0.01
+89%
-0.01
N/A
0.02
N/A
0.04
+100%
0.03
-25%
0.03
N/A
0.03
N/A
0.03
N/A
0.03
N/A
0.05
+67%
0.07
+40%
0.06
-14%
0.07
+17%
0.07
N/A
0.07
N/A
0.06
-14%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.